Healthcare Huddle

23andMe Files for Bankruptcy. Here’s What Happens to Your DNA

23andMe’s Collapse: Financial Woes, Layoffs, and Data Risks

GLP-1 Discontinuation: What It Means for Weight Loss Brands

OURA Ring: Partnerships, Acquisitions, and the Future of Wearables

The Future of Obesity Care: GLP-1s, Compounding & Surgery Trends

Huddle #Trends

Are Continuous Glucose Monitors Worth It for Those Without Diabetes?

CGM Wars: Who Will Lead the Future of Metabolic Health Monitoring?

23andMe’s New GLP-1 Service: Exploring Compounded Medications

How Guardian Angel Tech Will Transform the Wearable Tech Space

Your Comprehensive Guide to Women’s Health: Trends, Investments, Policy Impact in 2024

Women's Health Whitepaper

Women’s Health: Beyond Reproductive and Gynecological Care

Women's Health Series Part 1 of 3

Dexcom and Abbott’s FDA-Cleared CGMs: A Consumer Market Revolution